ArticleAcute medicine & surgery
A Case of Paroxysmal Sympathetic Hyperactivity due to Cardiogenic Shock.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Paroxysmal sympathetic hyperactivity (PSH) is characterized by excessive autonomic activation typically seen after severe brain injury. PSH has not previously been reported in association with cardiogenic shock. Here, we report a case of PSH during the treatment of cardiogenic shock with dilated cardiomyopathy. Case Presentation: A 60-year-old man with cardiogenic shock and dilated cardiomyopathy was transferred to our hospital. He was intubated and received an Impella support. On Day 4 post-admission, paroxysmal fever, tachycardia, tachypnea, and abnormal muscle tone were observed in the extremities. Antiepileptic drugs and broad-spectrum antibiotics were ineffective, and the seizure pattern suggested PSH; therefore, gabapentin was started on Day 27 post-admission. The seizures gradually resolved and eventually resolved. Conclusion: This case suggests that PSH may be triggered by functional disturbances in cerebral perfusion and autonomic regulation associated with cardiogenic shock, even in the absence of irreversible brain injury. When patients with cardiogenic shock present with paroxysmal tachycardia, tachypnea, and fever, PSH should be considered in the differential diagnosis. Early recognition of PSH may facilitate timely treatment and contribute to improved clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.